Detoxification and Treatment of Subjects With Medication Overuse Headache
NCT ID: NCT00432549
Last Updated: 2007-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
60 participants
INTERVENTIONAL
2007-01-31
2007-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Two Detoxification Protocols for Treatment of Medication-overuse Headache
NCT02903329
Frovatriptan as a Transitional Therapy in Medication Overuse Headache
NCT01044251
Is Detoxification Needed in Medication-overuse Headache?
NCT02993289
Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency
NCT04410536
Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.
NCT00212810
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Almotriptan
Topiramate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ortho-McNeil Neurologics, Inc.
INDUSTRY
The New England Center for Headache, P.C.
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fred D Sheftell, M.D.
Role: PRINCIPAL_INVESTIGATOR
The New England Center for Headache, P.C.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The New England Center for Headache, P.C.
Stamford, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAPSS-328
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.